{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:40Z","timestamp":1791821980896,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"crossref","award":["NMRC\/OFLCG\/004a\/2018"],"award-info":[{"award-number":["NMRC\/OFLCG\/004a\/2018"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"crossref","award":["NMRC\/LCG23 May\/0032"],"award-info":[{"award-number":["NMRC\/LCG23 May\/0032"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"crossref","award":["STaR 24-Jan-0005"],"award-info":[{"award-number":["STaR 24-Jan-0005"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40123-026-01366-5","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:41:30Z","timestamp":1774672890000},"page":"1907-1924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct002120950","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kelvin Yi Chong","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Ideta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuju","family":"Sekiryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Obana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusaburo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Y. Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Miyatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Obata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Machewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Chui ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"5","key":"1366_CR1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology. 2018;125(5):708\u201324.","journal-title":"Ophthalmology"},{"issue":"3","key":"1366_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/01.APO.0000656992.00746.48","volume":"9","author":"V Chaikitmongkol","year":"2020","unstructured":"Chaikitmongkol V, Cheung CMG, Koizumi H, Govindahar V, Chhablani J, Lai TYY. Latest developments in polypoidal choroidal vasculopathy: epidemiology, etiology, diagnosis, and treatment. Asia Pac J Ophthalmol (Phila). 2020;9(3):260\u20138.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"1366_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41433-021-01688-7","volume":"36","author":"BJ Fenner","year":"2022","unstructured":"Fenner BJ, Cheung CMG, Sim SS, Lee WK, Staurenghi G, Lai TYY, et al. Evolving treatment paradigms for PCV. Eye (Lond). 2022;36(2):257\u201365.","journal-title":"Eye (Lond)"},{"issue":"5","key":"1366_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","volume":"39","author":"CMG Cheung","year":"2025","unstructured":"Cheung CMG, Dansingani KK, Koizumi H, Lai TYY, Sivaprasad S, Boon CJF, et al. Pachychoroid disease: review and update. Eye (Lond). 2025;39(5):819\u201334.","journal-title":"Eye (Lond)"},{"issue":"1","key":"1366_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2025.100144","volume":"14","author":"P Ruamviboonsuk","year":"2025","unstructured":"Ruamviboonsuk P, Ng DSC, Chaikitmongkol V, Chang A, Chen SJ, Chen Y, et al. Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS). Asia Pac J Ophthalmol (Phila). 2025;14(1):100144.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"11","key":"1366_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, et al. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol. 2017;135(11):1206\u201313.","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"1366_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","volume":"138","author":"TH Lim","year":"2020","unstructured":"Lim TH, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, et al. Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial. JAMA Ophthalmol. 2020;138(9):935\u201342.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"1366_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40123-024-00888-0","volume":"13","author":"KYC Teo","year":"2024","unstructured":"Teo KYC, Park KH, Ngah NF, Chen SJ, Ruamviboonsuk P, Mori R, et al. Six-year outcomes in subjects with polypoidal choroidal vasculopathy in the EVEREST II Study. Ophthalmol Ther. 2024;13(4):935\u201354.","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"1366_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial. JAMA Ophthalmol. 2018;136(7):786\u201393.","journal-title":"JAMA Ophthalmol"},{"key":"1366_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","volume":"204","author":"TY Wong","year":"2019","unstructured":"Wong TY, Ogura Y, Lee WK, Iida T, Chen SJ, Mitchell P, et al. Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the aflibercept in polypoidal choroidal vasculopathy study. Am J Ophthalmol. 2019;204:80\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1366_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00417-021-05190-4","volume":"260","author":"HC Roh","year":"2022","unstructured":"Roh HC, Kim SJ, Kang SW, Eun JS, Choi KJ. Long-term outcomes of polypoidal choroidal vasculopathy in comparison with typical exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2022;260(1):83\u201392.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"1366_CR12","doi-asserted-by":"publisher","first-page":"e1579","DOI":"10.1111\/aos.15149","volume":"100","author":"JY Park","year":"2022","unstructured":"Park JY, Park YJ, Park SJ, Park KH, Yeo JH, Kim JG, et al. Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration-up to 10 years of follow-up. Acta Ophthalmol. 2022;100(8):e1579\u201388.","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"1366_CR13","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, Group S-US. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. 2013;120(11):2292\u20139.","journal-title":"Ophthalmology"},{"issue":"1","key":"1366_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration\u2014a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20(1):294.","journal-title":"BMC Ophthalmol"},{"key":"1366_CR15","first-page":"8210","volume":"13","author":"YW Huang","year":"2024","unstructured":"Huang YW, Meng LC, Shen LJ, Huang CF, Chen LK, Hsiao FY. Changing reimbursement criteria on Anti-VEGF treatment patterns among wet age-related macular degeneration and diabetic macular edema patients: an interrupted time series analysis. Int J Health Policy Manag. 2024;13:8210.","journal-title":"Int J Health Policy Manag"}],"updated-by":[{"DOI":"10.1007\/s40123-026-01401-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000}}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01366-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:27:12Z","timestamp":1781008032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01366-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01366-5","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to given name of the author James G Wong was incorrectly published as James G Franzco Wong. Now, the author name has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40123-026-01401-5","URL":"https:\/\/doi.org\/10.1007\/s40123-026-01401-5","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Kelvin Yi Chong Teo reports consultancy fees, honorarium, travel support and speaker fees from Bayer and Novartis outside the submitted work. Dr. Young Hee Yoon reports no relevant conflict of interest. Dr. Shigeru Honda reports support from Santen, Senju, Chugai, Alcon, HOYA, Novartis, and Bayer outside the submitted work. Dr. Kyu Hyung Park reports consultancy fees, honorarium, travel support and speaker fees from Bayer, Novartis, Alcon, Roche, Samsung Bioepis, Oculight, RetiMark outside the submitted work. Dr. Hidenori Takahashi reports consultancy fees, speaker honoraria, and travel support from Bayer and Novartis, and speaker honoraria from Santen, Senju, and Chugai, all outside the submitted work. He also reports financial support from SPS and Kyowa Kirin, and holds intellectual property and a founder position in DeepEyeVision. Dr. Ryuichi Ideta reports consultancy fees and speaker fees from Senju, Chugai, Santen, Novartis, and Kowa outside the submitted work. Dr Tetsuju Sekiryu reports support from Santen, Senju, Chugai, Alcon, HOYA, Novartis, and Bayer outside the submitted work. Dr. Akira Hirata reports consultancy fees and speaker fees from Novartis, Santen, Senju, and Kowa outside the submitted work. Dr. Akira Obana reports no relevant conflict of interest. Dr Ryusaburo Mori reports personal fees from Bayer Yakuhin Ltd., Chugai Pharmaceutical Co, Ltd., Novartis Pharma K.K, Senju Pharmaceutical Co, Ltd., Santen Pharmaceutical Co, Ltd, and Nippon Boehringer Ingelheim Co, Ltd. Dr. Shih Jen Chen reports consultation fees from Roche, Bayer, Novartis and Allergan outside the submitted work. Dr. Caroline Chee reports consultation fees from Roche, Speaker fees from Novartis outside the submitted work. Dr. James Wong reports consultancy fees and speaker honoraria from Bayer, Roche, and Apellis outside the submitted work. Dr. Timothy Lai reports consultancy fees, grants, travel support and speaker fees from Bayer, Novartis and Roche during the conduct of the study; consultancy fees, grants and speaker fees from 4DMT, Astellas, Bayer, Boehringer Ingelheim, Novartis, Ocular Therapeutix, Oculis, and Roche outside the submitted work. Dr. Ian Wong reports no relevant conflict of interest. Dr Nicholas Fung reports travel support from Alcon outside the submitted work. Dr. Won Ki Lee reports consultancy fees, travel support and speaker fees from Bayer, Novartis, Roche outside the submitted work. Dr. Hiroko Terasaki reports speaker fees from Alcon, Bayer, Santen, and Sanofi outside the submitted work. Dr. Shih-Chou Chen reports consultation fees from Roche, Bayer, Novartis and Allergan outside the submitted work. Dr Takafumi Miyatani reports no conflict of interest. Dr Tomohiro Iida reports support from Santen, Senju, Chugai, Novartis, Kyowa Kirin, Topcon and Bayer outside the submitted work. Dr Ryo Obata reports speaker fees from Bayer, Chugai, Novartis, Santen, and Senju outside the submitted work. Tobias Machewitz and Dr. Sergio Leal are employees of Bayer AG. Dr. Chui Ming Gemmy Cheung reports consultancy fees, honorarium, travel support and speaker fees from 4DMT, Astellas, Bayer, Novartis, Roche, Boehringer Ingelheim, Zeiss and Topcon outside the submitted work. Dr. Chui Ming Gemmy Cheung is an Editorial Board member of\n                      Ophthalmology and Therapy\n                      . Dr. Chui Ming Gemmy Cheung was not involved in selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the tenets of the Declaration of Helsinki and with approval of the respective institutional review boards of the participating centers (SingHealth IRB: R1597\/96\/2018). Written informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\/Ethical Approval"}}]}}